Drug Interaction Report

Selpercatinib and Sertraline: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Selpercatinib

Retevmo Retevmo®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 103 documented Selpercatinib interactions, 99 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Sertraline and selpercatinib can each prolong the QT interval, so together the risk adds up. Keep taking both as prescribed and let your care team monitor your EKG and electrolytes.

You've been prescribed sertraline (an antidepressant) and selpercatinib (a cancer medicine). Both can gently affect the timing of your heartbeat, something doctors call the QT interval. When two medicines that do this are taken together, the effect can add up, which in rare cases can lead to an irregular heartbeat.

Please don't worry or stop either medicine on your own. This is a known combination that your care team can manage. They'll usually check your heart rhythm with an EKG and look at your blood levels (like potassium and magnesium) before and during treatment. If you feel faint, dizzy, or notice a pounding or fluttering heartbeat, let them know right away.

Effect: Additive QTc prolongation from combined use of sertraline and selpercatinib. Both are independent QT-prolonging agents; neither is a prodrug relevant here, so the effect is pharmacodynamic (additive), not a change in metabolism.

  • Direction/magnitude: Increased risk of QTc prolongation and, rarely, torsades de pointes. Evidence is theoretical.
  • Onset: Unspecified.
  • Monitoring: Assess ECG/QTc, electrolytes (K+, Mg2+, Ca2+), and TSH at baseline and periodically; increase frequency with risk factors such as diarrhea.
  • Management: Correct hypokalemia, hypomagnesemia, and hypocalcemia before and during therapy. Withhold, dose-reduce, or discontinue selpercatinib per severity.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased risk of QT interval prolongation

Interaction Deep Dive

When selpercatinib is taken alongside other agents known to lengthen the QT interval, the QTc-prolonging actions of selpercatinib can be compounded. Measure the QT interval, electrolyte levels, and TSH before starting therapy and at intervals throughout treatment, tailoring how often these are checked according to risk factors such as diarrhea. Hypokalemia, hypomagnesemia, and hypocalcemia should be corrected both before selpercatinib is begun and over the course of treatment. Depending on the severity, selpercatinib may need to be interrupted and either dose-reduced or stopped altogether1.

Why it happens (mechanism)

Additive QT interval prolongation

How to manage this interaction

This combination is manageable with monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise.

  • Your team will likely check an EKG (heart rhythm) and blood electrolytes (potassium, magnesium, calcium) and thyroid (TSH) before starting and periodically during treatment.
  • They may check more often if you have risk factors such as diarrhea, which can lower electrolytes.
  • Any low electrolytes will be corrected before and during treatment.
  • Your selpercatinib dose may be adjusted and individualized by your care team based on results.

Tell your pharmacist or prescriber promptly about fainting, dizziness, or a fluttering or pounding heartbeat.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Selpercatinib and Sertraline together?

Sertraline and selpercatinib can each prolong the QT interval, so together the risk adds up. Keep taking both as prescribed and let your care team monitor your EKG and electrolytes. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Selpercatinib and Sertraline interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Selpercatinib and Sertraline interaction managed?

This combination is manageable with monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Your team will likely check an EKG (heart rhythm) and blood electrolytes (potassium, magnesium, calcium) and thyroid (TSH) before starting and periodically during treatment. They may check more often if you have risk factors such as diarrhea, which can lower e… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Selpercatinib or Sertraline need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: RETEVMO(R) oral capsules, tablets, selpercatinib oral capsules, tablets. Lilly USA LLC (per FDA), Indianapolis, IN, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.